(Total Views: 488)
Posted On: 05/01/2018 7:05:27 PM
Post# of 721
NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Renews Licensing Agreement with Nuka Enterprises
Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) recently announced a new licensing agreement with Nuka Enterprises LLC to renew Nuka’s DehydraTECH™ license rights for use in its 1906 brand of cannabis chocolates. Nuka and 1906 have also acquired new rights in product categories in addition to the original chocolate formats, including candies, beverages, capsules and pills, and topical creams. “Nuka’s success with the 1906 brand of cannabis chocolates – recognized for their fast onset times, efficacy, taste and unique formulations – clearly demonstrate the market potential for DehydraTECH™. This comprehensive, long-term relationship between Nuka and Lexaria is poised to redefine the cannabis industry and holds great potential for us in other markets,” Lexaria CEO Chris Bunka stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) recently announced a new licensing agreement with Nuka Enterprises LLC to renew Nuka’s DehydraTECH™ license rights for use in its 1906 brand of cannabis chocolates. Nuka and 1906 have also acquired new rights in product categories in addition to the original chocolate formats, including candies, beverages, capsules and pills, and topical creams. “Nuka’s success with the 1906 brand of cannabis chocolates – recognized for their fast onset times, efficacy, taste and unique formulations – clearly demonstrate the market potential for DehydraTECH™. This comprehensive, long-term relationship between Nuka and Lexaria is poised to redefine the cannabis industry and holds great potential for us in other markets,” Lexaria CEO Chris Bunka stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
